The University of Illinois Chicago will be the first site in the state to participate in a national study of a clinical test that screens for a shared cancer signal in a sample of patient blood. The test screens for a signal shared by more than 50 types of cancers, including pancreatic and blood cancers which do not currently have recommended screening tests and often go undetected until later stages.
